Presentations and Publications
Read about publications and presentations made by Benitec's scientific team below. For details of Benitec's announcements to NASDAQ, read details in our Investor Centre.2018
BB-301: A Single “Silence and Replace” AAV-Based Vector for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)
The 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Chicago
May 18, 20182017
Gene therapy for oculopharyngeal muscular dystrophy
The 22nd International Annual Congress of the World Muscle Society
Oct 6, 2017
Towards Development of a ‘Silence and Replace’ Based Approach for the Treatment of Oculopharyngeal Muscular Dystrophy.
Joint 10th AGCST and ASSCR Scientific Meeting, Sydney
May 25, 2017
PABPN1 gene therapy for oculopharyngeal muscular dystrophy
Nat. Commun. 8, 14848 doi: 10.1038/ ncomms14848 (2017)
Jan 1, 20172016
Gene Therapy Rescues Disease Phenotype in the Oculopharyngeal Muscular Dystrophy Mouse Model
ASGCT 19th Annual Meeting, Washington DC
May 5, 2016